Condiciones de salud que trébol rojo puede ayudar a apoyar.
Red clover contains multiple antioxidant constituents — isoflavones (genistein, daidzein), flavonoids, anthocyanins, and coumarins — with documented free radical scavenging activity. In vitro studies demonstrate suppression of LPS-induced reactive oxygen species and activation of antioxidant signaling (Nrf2 pathway). Genistein and daidzein have published antioxidant activity of physiological relevance.
Multiple clinical trials demonstrate that red clover isoflavones improve systemic arterial compliance (elasticity) in menopausal and normotensive populations. A landmark Nestel et al. RCT (J Clin Endocrinol Metab 1999) found a 23% improvement in arterial compliance at 80 mg/day isoflavones. A larger AHA-published RCT confirmed reduction in arterial stiffness and total vascular resistance. Ambulatory blood pressure was unaffected in most studies.
Evidence for red clover's effect on blood pressure is mixed. Most RCTs in normotensive populations show no significant change. However, a small crossover RCT in postmenopausal women with type 2 diabetes found significantly lower daytime systolic and diastolic ambulatory blood pressure during isoflavone therapy. Effects may be context-dependent (hypertension or metabolic comorbidity).
Red clover isoflavones have been clinically investigated for their ability to slow bone mineral density (BMD) loss in postmenopausal women. A 12-week randomized, double-blind, placebo-controlled trial (n=60) showed that only the placebo group experienced a significant decline in lumbar spine BMD. A 3-year safety study also detected differences in bone turnover markers between active and placebo groups. Results across trials are directionally positive but not fully consistent.
Multiple RCTs and two meta-analyses have examined red clover isoflavones and serum lipids. A 2020 meta-analysis (10 RCTs, n=910) found significant total cholesterol reduction; a 2022 meta-analysis added significant HDL increases. Results are mixed for LDL, with some individual trials showing significant LDL reductions and others showing no effect. Effects appear most consistent in postmenopausal women with dyslipidemia.
Red clover isoflavones and anthocyanins have demonstrated anti-inflammatory activity in preclinical models, suppressing key pro-inflammatory pathways. In vitro, red clover isoflavones reduced expression of TNF-α, IL-1β, iNOS, and COX-2 in LPS-stimulated macrophages via NF-κB and p38 MAPK inhibition. Human clinical evidence for systemic inflammation remains largely indirect through cardiovascular and menopausal studies.
Red clover (Trifolium pratense) contains four phytoestrogenic isoflavones—formononetin, biochanin A, daidzein, and genistein—that bind ERβ and function as tissue-selective SERMs. RCT evidence for hot flash reduction is mixed; some trials show benefit at ≥120 mg isoflavones/day. It is among the most researched phytoestrogen sources for menopausal estrogen balance.
Preliminary evidence suggests red clover isoflavones may support hair growth by extending the anagen (growth) phase of the hair cycle, increasing dermal papilla growth factors, and stabilizing the extracellular matrix. One clinical observation reported improved scalp, hair, and skin health in adult women within 90 days. Evidence remains limited and primarily mechanistic.
Red clover isoflavones have been studied in multiple RCTs for cardiovascular effects including arterial compliance, lipid profile, and blood pressure. Benefits are most consistent for improved arterial elasticity; effects on lipids are mixed across trials but a 2020 meta-analysis found a significant reduction in total cholesterol. Overall, cardioprotective effects appear modest and primarily relevant to peri/postmenopausal women.
Red clover (Trifolium pratense) isoflavones have been evaluated in multiple RCTs for menopausal hot flashes. A 2021 systematic review and meta-analysis of 8 trials found a statistically significant reduction of approximately 1.73 hot flashes per day versus placebo. Individual RCTs show reductions in hot flush frequency from the first month of supplementation.
Red clover (Trifolium pratense) contains isoflavones (biochanin A, formononetin, daidzein, genistein) that act as phytoestrogens via estrogen receptor-beta binding. A 2021 meta-analysis of 8 RCTs showed a statistically significant reduction of ~1.73 hot flashes/day vs. placebo. A 2024 RCT of 75 postmenopausal women found significant improvements in Menopause Rating Scale scores at 3 and 6 months.
Red clover is rich in isoflavones (biochanin A, formononetin, genistein, daidzein) that act as phytoestrogens with bone-protective effects. A 12-month double-blind RCT in 205 postmenopausal women showed red clover-derived isoflavones significantly reduced lumbar spine BMD loss compared to placebo. It is one of the most-studied botanical sources of phytoestrogens for postmenopausal bone health.
Red clover (Trifolium pratense) is rich in isoflavones (formononetin, biochanin A, daidzein, genistein) with anti-androgenic and phytoestrogenic properties. Preliminary clinical evidence and systematic reviews support its use for androgen reduction and hormonal balance in PCOS.
Red clover (Trifolium pratense) contains isoflavones—formononetin, biochanin A, daidzein, and genistein—that act as phytoestrogens, binding estrogen receptors to produce weak estrogenic effects. A review of 4 RCTs showed one trial with significant hot flash reduction versus placebo. Doses of 40–80 mg isoflavones/day are commonly used.
Red clover isoflavones have been shown in animal studies to reduce skin aging induced by estrogen deprivation by increasing collagen content, skin thickness, and improving dermal architecture. In vitro studies confirm stimulation of fibroblast migration and collagen production. Some clinical observations support improvements in skin aging signs in postmenopausal women at 40–80 mg/day.
Red clover isoflavones stimulate collagen production and fibroblast migration in preclinical models, with demonstrated increases in dermal collagen content in ovariectomized rats. In vitro studies confirm that red clover extract supports fibroblast proliferation and collagen synthesis through estrogen-dependent and oxidative stress pathways. Oral and topical applications are both explored.
Several RCTs and a meta-analysis indicate that red clover isoflavones can reduce triglyceride levels, particularly in postmenopausal women. A crossover RCT of 60 postmenopausal women (80 mg/day for 90 days) found triglyceride levels significantly lower with red clover versus placebo. A 2019 systematic review found a non-significant trend toward triglyceride reduction across pooled studies.
Clinical trials show that red clover isoflavones improve vaginal cytology indices in postmenopausal women, reflecting a local estrogenic effect on vaginal epithelium. A randomized crossover RCT (n=60) showed significantly improved karyopyknotic, cornification, and basal cell maturation indices. A ScienceDirect monograph confirms positive effects on vaginal cytology as a documented trial outcome.
Red Clover is traditionally used in herbal medicine as a blood cleanser to support the resolution of abscesses, with specific mention of its action in thinning cyst walls to promote drainage. It is included in historical herbalist formulas for abscess treatment.
Red clover has a documented traditional use for acne through its historical role as an 'alterative' or blood-purifying herb. Multiple monograph sources list acne as a traditional indication. The EBSCO Research database notes preliminary evidence may be beneficial for acne. No dedicated clinical trials have been identified.
Arthritis and joint pain are consistently documented traditional uses of red clover across European, Asian, and North American herbal medicine. Multiple monographs list arthritis as a traditional indication. Isoflavone anti-inflammatory mechanisms provide plausible rationale, but no clinical trial evidence specific to arthritis has been identified.
Asthma is one of the most consistently documented traditional indications for red clover across multiple herbal traditions, including European, Chinese, and North American medicine. The plant was used for its antispasmodic effects on bronchial smooth muscle. No clinical trial evidence for asthma has been identified.
Red clover flowers have been traditionally used as a topical poultice for insect bites and stings, documented in Western herbal references. The application relied on the anti-inflammatory and soothing properties of the plant. No clinical evidence exists for this specific use.
Red clover contains coumarin derivatives (including coumarin, medicagol, and coumestrol) that may exert mild anticoagulant effects. Historically it was considered a 'blood purifier' and used to promote circulation. There are case reports of bleeding events in users, and preclinical studies suggest it may enhance the effects of anticoagulant medications, but no robust clinical RCTs support blood clot prevention as an indication.
Red clover flowers have a centuries-old traditional use across European, Chinese, and North American herbal medicine as a remedy for bronchial conditions including bronchitis, whooping cough, and asthma. It was used as an expectorant and antispasmodic to relax bronchial smooth muscle and promote mucus clearance. No clinical trial evidence for bronchial health exists.
Bronchitis is a well-documented traditional indication for red clover flowers across European and Asian herbal medicine. Multiple monograph sources cite its use as an expectorant and anti-inflammatory remedy for bronchitis. No clinical trial evidence has been identified.
Red clover was historically regarded as a 'blood purifier' and circulatory tonic across multiple herbal traditions. Drugs.com records that it was 'thought to purify the blood by promoting urine and mucus production, improving circulation.' Scientific evidence for arterial compliance improvement provides partial modern support for the circulation link.
Red clover has a well-documented tradition across European, North American, and Chinese herbal medicine as a remedy for eczema, applied both topically as an ointment and taken internally. Multiple authoritative monographs (drugs.com, MSKCC, ScienceDirect) confirm this traditional use. No clinical RCT evidence specifically for eczema has been identified.
Red clover contains isoflavones (formononetin, biochanin A) with phytoestrogenic activity that may support follicular development and cervical mucus in women with relatively low estrogen. It has been used traditionally for female reproductive support. Limited clinical evidence exists specifically for fertility; most is in menopausal symptom management.
Gout is a consistently listed traditional indication for red clover across herbalism traditions in Europe and Asia. Multiple clinical monographs document its traditional use for gout and associated joint pain. No clinical trial evidence specifically evaluating red clover for gout or uric acid reduction has been identified.
Red clover has a well-documented traditional use for lung health, particularly for respiratory conditions such as whooping cough, bronchitis, and asthma. Traditional Chinese Medicine used it as a cough suppressant and antitussive agent. No clinical trial evidence specifically for lung health exists.
Red clover (Trifolium pratense) is one of the most-recommended traditional lymphatic herbs in Western and naturopathic practice, used as a blood cleanser and lymphatic tonic. It contains isoflavones including biochanin A, which modulate NF-κB and MAPK signaling pathways relevant to vascular and lymphatic function. Its isoflavones also include natural coumarins—a class of benzopyrones studied in numerous clinical trials for lymphedema.
Red Clover (Trifolium pratense) has longstanding use in Western herbalism as a blood purifier and alterative, traditionally recommended for swollen glands, chronic lymphatic congestion, and skin eruptions thought to arise from lymphatic stagnation. Its isoflavone content has been studied for menopausal and cardiovascular effects, but direct clinical evidence for lymphatic function remains traditional. A 2020 meta-analysis of 8 RCTs confirmed isoflavone activity for menopausal symptoms; lymphatic-vessel claims remain empirical.
Mastitis is a consistently cited traditional indication for red clover across multiple authoritative sources including MSKCC, CancerNetwork, and drugs.com. Traditional use involved both internal preparations and topical poultices for mastitis. No clinical trial evidence has been identified.
Red clover is traditionally classified as an expectorant herb, promoting the clearance of mucus from the respiratory tract. Multiple traditional herbal medicine systems used it to thin mucus and stimulate expectoration from the bronchi. No clinical trial evidence exists for this specific use.
Red clover (Trifolium pratense) blossoms were among the four key remedies favored by 19th-century Eclectic physicians specifically for pertussis. The 2006 Abascal and Yarnell peer-reviewed review listed it among pre-vaccine botanical treatments for pertussis. It is referenced as an age-old remedy for whooping cough for its lymphatic, expectorant, and anti-inflammatory properties.
Red clover (Trifolium pratense) contains isoflavones—formononetin, biochanin A, daidzein, and genistein—that act as phytoestrogens. It has been traditionally used for menopausal and menstrual complaints including PMS, with some small clinical studies on menopausal symptoms and preliminary evidence from the broader phytoestrogen literature.
Red clover has a long-documented tradition as a topical and internal remedy for psoriasis. It was listed in the US National Formulary as a skin remedy until 1946. Topical ointments containing red clover are traditionally applied to psoriatic lesions. There is no verified clinical trial evidence specifically for psoriasis. One case report describes toxicity when red clover was used alongside methotrexate for severe psoriasis.
Red clover ointments and poultices have a documented traditional use for soothing skin rashes. Drugs.com explicitly lists treatment of rashes as a traditional topical indication. This use is shared across European and North American herbal traditions but is not supported by clinical trial data.
Red clover (Trifolium pratense) contains isoflavones that bind estrogen receptor sites and modulate estrogenic activity, providing traditional use as a uterine tonic and fertility herb. Its phytoestrogens are used to prepare the uterus for pregnancy and to manage menopausal symptoms. Clinical evidence focuses more on menopausal hot flashes than direct uterine structural effects.
Red clover has a traditional use for topical wound healing, documented in herbal monographs and the drugs.com clinical reference. Preclinical in vitro evidence from 2026 (PMC12944059) shows red clover extract enhances fibroblast migration — a key step in wound closure. No clinical RCT evidence for wound healing exists.
Volver